Articles by G. Boka (2)

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

R. E. Ratner, J. Rosenstock and G. Boka

Diabetic Medicine 27 ( 9 ): 1024 - 1032 , 2010

Efficacy and safety of lixisenatide once daily vs. placebo in people with Type 2 diabetes insufficiently controlled on metformin (GetGoal-F1)

G. B. Bolli, M. Munteanu, S. Dotsenko, E. Niemoeller, G. Boka, Y. Wu and M. Hanefeld

Diabetic Medicine 31 ( 2 ): 176 - 184 , 2014

Do you have a suggestion for journals

Suggest Journal